GEN.TO - GeneNews Limited

Toronto - Toronto Delayed Price. Currency in CAD

GeneNews Limited

445 Apple Creek Boulevard
Unit 220
Markham, ON L3R 9X7

IndustryDiagnostics & Research
Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Mr. James R. Howard-TrippExec. Chairman & CEO270kN/AN/A
Ms. Leslie Auld MBA, CPA, CACFO, Treasurer & Director150.97kN/AN/A
Ms. Joanna M. Halsey Esq.Gen. Counsel, Chief Compliance Officer & HR Director of IDL165kN/AN/A
Prof. Choong-Chin Liew Ph.D.Co-FounderN/AN/AN/A
Mr. David SuriaSr. ScientistN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is based in Markham, Canada.

Corporate Governance

GeneNews Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.